SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007617
Filing Date
2024-05-09
Accepted
2024-05-09 16:15:34
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q enfn-20240331x10q.htm   iXBRL 10-Q 1243650
2 EX-31.1 enfn-20240331xex31d1.htm EX-31.1 12456
3 EX-31.2 enfn-20240331xex31d2.htm EX-31.2 11704
4 EX-32.1 enfn-20240331xex32d1.htm EX-32.1 5036
5 EX-32.2 enfn-20240331xex32d2.htm EX-32.2 5045
  Complete submission text file 0001558370-24-007617.txt   5218761

Data Files

Seq Description Document Type Size
6 EX-101.SCH enfn-20240331.xsd EX-101.SCH 35060
7 EX-101.CAL enfn-20240331_cal.xml EX-101.CAL 45254
8 EX-101.DEF enfn-20240331_def.xml EX-101.DEF 190522
9 EX-101.LAB enfn-20240331_lab.xml EX-101.LAB 354569
10 EX-101.PRE enfn-20240331_pre.xml EX-101.PRE 273434
66 EXTRACTED XBRL INSTANCE DOCUMENT enfn-20240331x10q_htm.xml XML 673433
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40949 | Film No.: 24930865
SIC: 7372 Services-Prepackaged Software
(CF Office: 06 Technology)